Cook eyes December launch for pelvic congestion syndrome diagnostic:
This article was originally published in Clinica
Cook Women's Health plans to complete the CE-marking of its transcervical pelvic venogram (TPV) set for diagnosing pelvic congestion syndrome (PCS), by December 2006. The test, which is already approved in the US for performing basic hysterograms and transcervical venography, works by injecting a water-soluble, radiopaque contrast medium into the fundal myometrium at the top of the uterus. The medium is picked up by the veins and then monitored using fluoroscopic imaging. PCS is characterised by hyperdilated vasculature and poor clearance of the dye. PCS is one of the many causes of chronic pelvic pain, and affects around 15% of women aged 18-50, claims Cook.
You may also be interested in...
Topline results with AZD1222 have shown a lower efficacy rate than the Pfizer and Moderna vaccines, but a subgroup receiving a half-dose in their first injection showed a 90% efficacy result.
Krka’s bottom line continues to be stronger than usual, driven by a hike in sales and leaner cost base. Looking to 2021, however, management brought investors back down to earth.
The COVID-19 pandemic has triggered extraordinary levels of collaboration. But competition remains, and many newly created coalitions have yet to be stress tested.